Related Experiment Video
Updated: Aug 20, 2025

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
[Parkinson's disease and type 2 diabetes mellitus: interrelation of pathogenetic mechanisms and general therapeutic
1Russian Medical Academy for Continuous Professional Education, Moscow, Russia.
Abstract:
The review article discusses the epidemiological, clinical and pathophysiological aspects of the relationship between Parkinson's disease (PD) and type 2 diabetes mellitus (DM2). DM2 increases the risk of PD, correlates with the rate of its progression and severity of motor and cognitive deficits. The key link in the pathogenesis of both diseases can be insulin resistance that occurs in peripheral tissues in DM2 and in the brain in PD. In this regard, the use of antidiabetic drugs as neuroprotective agents opens up the possibility of developing a new strategy for targeted therapy that modifies the course of PD.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

